PRKN and Parkinson disease: Observations from idiopathic and parkin loss-of-function PD patient tissue and models indicate that NADH-ubiquinone oxidoreductase (respiratory chain complex I) function and reduced glutathione (GSH) levels are decreased [13,14,15,16].